Treatment of invasive candidiasis in the elderly: a review

Area of Science:

• Medical Mycology
• Infectious Diseases
• Geriatrics

Background:

• Fungi, particularly Candida species, are significant causes of infection in immunocompromised and elderly patients.
• Candida is the fourth leading cause of nosocomial bloodstream infections, with a higher incidence in individuals over 65.
• The aging population presents unique physiological vulnerabilities increasing susceptibility to Candida colonization and infection.

Purpose of the Study:

• To review the challenges of invasive Candida infections in elderly patients.
• To evaluate the safety and efficacy of different antifungal drug classes.
• To provide recommendations for antifungal therapy in older adults with invasive candidiasis.

Main Methods:

• Literature review of antifungal therapies for invasive fungal infections.
• Analysis of drug classes, focusing on safety profiles and drug-drug interactions.
• Evaluation of efficacy against common and resistant Candida strains.

Main Results:

• Echinocandins demonstrate activity against resistant Candida strains like Candida glabrata and Candida krusei.
• Echinocandins exhibit a favorable safety profile with fewer adverse events and drug-drug interactions compared to other antifungal agents.
• These characteristics make echinocandins a preferred choice for treating invasive Candida infections in the elderly.

Conclusions:

• Invasive Candida infections pose a significant threat to the elderly population.
• Echinocandins are a safe and effective treatment option for invasive candidiasis in older patients.
• Therapeutic decisions must consider patient comorbidities and concurrent medications.